ESCMID publications
Medical guidelines
Medical guidelines endorsed by ESCMID
- Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America.
Nicolle LE, Gupta K, Bradley SF et al. Clin Infect Dis 2019 pii: ciy1121. doi: 10.1093/cid/ciy1121. - ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children. Warris A, Lehrnbecher T et al. Clin Microbiol Infect. 2019 25(9):1096-1113. doi: 10.1016/j.cmi.2019.05.019.
- ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers. Tacconelli E., Mazzaferri E. et al. Clin Microbiol Infect. 2019,25:807-817. doi.org/10.1016/j.cmi.2019.01.005.
- EHRA international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by HRS, APHRS, LAHRS, ISCVID and ESCMID in collaboration with EACTS. Blomström-Lundqvist C, Traykov V at al. Eur J Cardiothorac Surg. 2019 Nov 14. pii: ezz296. doi: 10.1093/ejcts/ezz296.
- ESCMID generic competencies in antimicrobial prescribing
and stewardship: towards a European consensus.
Dyar OJ, Beović B, Pulcini C, Tacconelli E, Hulscher M, Cookson B;
Clin Microbiol Infect 2019;25:13-19. doi: 10.1016/j.cmi.2018.09.022 - Consensus document for the diagnosis of prosthetic joint
infections: a joint paper by the EANM, EBJIS, and ESR
(with ESCMID endorsement).
Signore A, Sconfienza LM, Borens O, et al. Eur J Nucl Med Mol Imaging 2019.
doi: 10.1007/s00259-019-4263-9 - Correction to: consensus document for the diagnosis of
prosthetic joint infections: a joint paper by the EANM,
EBJIS, and ESR (with ESCMID endorsement).
Signore A, Sconfienza LM, Borens O, et al. Eur J Nucl Med Mol Imaging 2019.
doi: 10.1007/s00259-019-04281-z. - International consensus guidelines for the optimal use of
the polymyxins: endorsed by ACCP, ESCMID, IDSA, ISAP, SCCM,
and SIDP.
Tsuji BT, Pogue JM, Zavascki AP, et al. Pharmacotherapy 2019;39:10-39.
doi: 10.1002/phar.2209. - ESICM/ESCMID task force on practical management
of invasive candidiasis in critically ill patients.
Martin-Loeches I, Antonelli M, Cuenca-Estrella M, et al. Intensive Care Med 2019;1-17. doi: 10.1007/s00134-019-05599-w. - Diagnosis of peripheral bone and prosthetic joint infections: overview on the consensus documents by the EANM, EBJIS, and ESR (with ESCMID endorsement).
Sconfienza LM, Signore A, Cassar-Pullicino V et al. Eur Radiol 2019 doi: 10.1007/s00330-019-06326-1. - Defining breakthrough invasive fungal infection-Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology.
Cornely OA, Hoenigl M, Lass-Flörl C et al. Mycoses 2019. doi: 10.1111/myc.12960. - Joint EANM/ESNR and ESCMID-endorsed consensus document for the diagnosis of spine infection (spondylodiscitis) in adults.
Lazzeri E, Bozzao A, Cataldo MA et al. Eur J Nucl Med Mol Imaging 2019 doi: 10.1007/s00259-019-04393-6. - Screening for carriage of carbapenem-resistant Enterobacteriaceae in settings of high endemicity: a position paper from an Italian working group on CRE infections.
Ambretti S, Bassetti M, Clerici P et al. Antimicrob Resist Infect Control 2019;8:136. doi: 10.1186/s13756-019-0591-6.
EUCAST
- The quality of antimicrobial discs from nine manufacturers-EUCAST
evaluations in 2014 and 2017.
Åhman J, Matuschek E, Kahlmeter G. Clin Microbiol Infect 2019;25:346-352.
doi: 10.1016/j.cmi.2018.05.021. - The proposed Drug Resistance Index (DRI) is not a good measure of antibiotic effectiveness in relation to drug resistance.
Vandenbroucke-Grauls CMJE, Kahlmeter G, Kluytmans J et al. BMJ Glob Health 2019;4:e001838. doi: 10.1136/bmjgh-2019-001838. - EUCAST evaluation of 21 brands of Mueller-Hinton dehydrated media for disk diffusion testing.
Åhman J, Matuschek E, Kahlmeter G. Clin Microbiol Infect 2020. pii: S1198-743X(20)30043-4. doi: 10.1016/j.cmi.2020.01.018. - VetCAST Method for Determination of the Pharmacokinetic-Pharmacodynamic Cut-Off Values of a Long-Acting Formulation of Florfenicol to Support Clinical Breakpoints for Florfenicol Antimicrobial Susceptibility Testing in Cattle.
Toutain PL, Sidhu PK, Lees P, et al. Front Microbiol 2019;10:1310. doi: 10.3389/fmicb.2019.01310. - Semi-Mechanistic Modeling of Florfenicol Time-Kill Curves and in silico Dose Fractionation for Calf Respiratory Pathogens.
Pelligand L, Lees P, Sidhu PK, Toutain PL. Front Microbiol 2019;10:1237. doi: 10.3389/fmicb.2019.01237. - Point-Counterpoint: Differences between the European Committee on Antimicrobial Susceptibility Testing and Clinical and Laboratory Standards Institute Recommendations for Reporting Antimicrobial Susceptibility Results.
Kahlmeter G, Giske CG, Kirn TJ, Sharp SE. J Clin Microbiol. 2019;57(9). pii: e01129-19. doi: 10.1128/JCM.01129-19. - EUCAST disc diffusion criteria for the detection of mecA-Mediated β-lactam resistance in Staphylococcus pseudintermedius: oxacillin versus cefoxitin.
Skov R, Varga A, Matuschek E, et al. Clin Microbiol Infect 2020;26(1):122.e1-122.e6. doi: 10.1016/j.cmi.2019.05.002. - Standards for MIC testing that apply to the majority of bacterial pathogens should also be enforced for Mycobacterium tuberculosis complex.
Schön T, Matuschek E, Mohamed S, et al. Clin Microbiol Infect 2019;25(4):403-405. doi: 10.1016/j.cmi.2019.01.019. - EUCAST Reference Testing of Rezafungin Susceptibility and Impact of Choice of Plastic Plates.
Arendrup MC, Jørgensen KM, Hare RK, et al. Antimicrob Agents Chemother 2019;63(9). pii: e00659-19. doi: 10.1128/AAC.00659-19 - Development and multicentre validation of an agar-based screening method for echinocandin susceptibility testing of Aspergillus species.
Meletiadis J, Siopi M, Kanioura L, et al. J Antimicrob Chemother 2019;74(8):2247-2254. doi: 10.1093/jac/dkz154. - The EUCAST rapid disc diffusion method for antimicrobial susceptibility testing directly from positive blood culture bottles.
Jonasson E, Matuschek E, Kahlmeter G. J Antimicrob Chemother 2020. pii: dkz548. doi: 10.1093/jac/dkz548. - Reply from Kahlmeter and Giske to Brecher, 'EUCAST and CLSI Point-Counterpoint on Susceptibility Breakpoints: Do Two "I Agree"s Miss the Point?'
Kahlmeter G, Giske CG. J Clin Microbiol 2019;58(1). pii: e01519-19. doi: 10.1128/JCM.01519-19.
EITaF
- Monkeypox - Enhancing public health preparedness for an emerging lethal human
zoonotic epidemic threat in the wake of the smallpox post-eradication era.
Petersen E, Abubakar I, Ihekweazu C, et al. Int J Infect Dis 2019;78:78-84.
doi: 10.1016/j.ijid.2018.11.008. - MDR/XDR-TB management of patients and contacts: challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network.
Battista Migliori G, Tiberi S, Zumla A, et al. Int J Infect Dis 2020. pii: S1201-9712(20)30045-X. doi: 10.1016/j.ijid.2020.01.042.
EUCIC
- Analysis of the challenges in implementing guidelines to prevent the spread of multidrug-resistant gram-negatives in Europe.
Tacconelli E et al. BMJ Open 2019;9:e027683. doi: 10.1136/bmjopen-2018-027683.
TAE
- Current mentorship practices in the training of the next generation of clinical
microbiology and infectious disease specialists: an international cross-sectional survey.
Ong DSY, Zapf TC, Cevik M, et al. Eur J Clin Microbiol Infect Dis 2019. doi: 10.1007/s10096-019-03509-y. - The Convergent Effect of International Collaboration between Young Leaders of Two Global Societies: Strengthening Microbiology Education and Training Practices Worldwide.
Meštrović T, Cevik M, Pinto TCA, Barać A, Servín-Garcidueñas LE, Ong DSY.J Microbiol Biol Educ 2019;20. pii: 20.1.27. doi: 10.1128/jmbe.v20i1.1669.
Position Papers
- EHRA international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections—endorsed by the HRS, APHRS, LAHRS, ISCVID and the ESCMID in collaboration with the EACTS
Blomström-Lundqvist C, Traykov V, Erba PA et al. Eur J Cardiothorac Surg. 2020 Jan 1;57(1):e1-e31. doi: 10.1093/ejcts/ezz296. - ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus
Document on the safety of targeted and biological therapies: an infectious diseases
perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22,
CD30, CD33, CD38, CD40, SLAMF-7 and CCR4).
Drgona L, Gudiol C, Lanini S, Salzberger B, Ippolito G, Mikulska M. Clin Microbiol Infect 2018;24:S83-S94. doi: 10.1016/j.cmi.2018.03.022. - ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus
Document on the safety of targeted and biological therapies: an infectious diseases
perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents).
Baddley JW, Cantini F, Goletti D, et al. Clin Microbiol Infect 2018;24:S10-S20. doi: 10.1016/j.cmi.2017.12.025 - ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus
Document on the safety of targeted and biological therapies: an infectious diseases
perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors).
Reinwald M, Silva JT, Mueller NJ, et al. Clin Microbiol Infect 2018;24:S53-S70. doi: 10.1016/j.cmi.2018.02.009 - ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus
Document on the safety of targeted and biological therapies: an infectious diseases
perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and
CD52).
Mikulska M, Lanini S, Gudiol C, et al. Clin Microbiol Infect 2018;24:S71-S82. doi: 10.1016/j.cmi.2018.02.003. - ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus
Document on the safety of targeted and biological therapies: an infectious diseases
perspective (Soluble immune effector molecules [II]: agents targeting interleukins,
immunoglobulins and complement factors).
Winthrop KL, Mariette X, Silva JT, et al. Clin Microbiol Infect 2018;24:S21-S40. doi: 10.1016/j.cmi.2018.02.002. - ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus
Document on the safety of targeted and biological therapies: an infectious diseases
perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-
phosphate receptor modulators and proteasome inhibitors).
Redelman-Sidi G, Michielin O, Cervera C, et al. Clin Microbiol Infect 2018;24:S95-S107. doi: 10.1016/j.cmi.2018.01.030. - ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus
Document on the safety of targeted and biological therapies: an infectious diseases
perspective (Introduction).
Fernández-Ruiz M, Meije Y, Manuel O,et al. Clin Microbiol Infect 2018;24:S2-S9. doi: 10.1016/j.cmi.2018.01.029 - Editorial for ESCMID Study Group for Infections in Compromised Hosts (ESGICH)
Consensus Document on the safety of targeted and biological therapies:
an infectious diseases perspective.
Aguado JM, Manuel O. Clin Microbiol Infect 2018;24 S1. doi: 10.1016/j.cmi.2018.04.02 - To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a
position paper of ESGBOR, the ESCMID study group for Lyme borreliosis.
Dessau RB, van Dam AP, Fingerle V, et al. Clin Microbiol Infect 2018;24:118-124. doi: 10.1016/j.cmi.2017.08.025. - Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP).
Tabah A, Bassetti M, Kollef MH, et al. Intensive Care Med 2019. doi: 10.1007/s00134-019-05866-w.
Publications from study groups
EFISG
- Invasive Pulmonary Aspergillosis treatment duration in haematology patients in Europe: an EFISG, IDWP‐EBMT, EORTC‐IDG, SEIFEM survey
Lanternier F, Seidel D, Pagano L, et al. Mycoses 2020. doi: 10.1111/myc.13056
EFWISG
- Food-to-Humans Bacterial Transmission.
Antunes P, Novais C, Peixe L. Microbiol Spectr 2020;8(1). doi: 10.1128/microbiolspec.MTBP-0019-2016.
ESGAI
- Antimicrobial susceptibility profiles of anaerobic bacteria, isolated from human clinical specimens, within different European and surrounding countries. A joint ESGAI study.
Veloo ACM, Tokman HB, Jean-Pierre H et al,. Anaerobe 2019:102111. doi: 10.1016/j.anaerobe.2019.102111. - Comparing identification of clinically relevant Prevotella species by VITEK MS and MALDI biotyper.
Toprak NU, Veloo ACM, Urban E, et al. Acta Microbiol Immunol Hung 2019. doi: 10.1556/030.66.2019.022.
ESGAP
- Preparedness to prescribe antibiotics responsibly: a comparison between
final year medical students in France and Sweden.
Dyar OJ, Lund M, Lindsjö C, Stålsby Lundborg C, Pulcini C. Eur J Clin Microbiol Infect Dis 2019.
doi: 10.1007/s10096-019-03494-2. - Practices, organisation, and regulatory aspects in advising on antibiotic prescription:
the international ESCMID AntibioLegalMap survey.
Tebano G, Dyar OJ, Beovic B, et al. Infection 2019;1-12. doi: 10.1007/s15010-019-01298-2. - Comparison of antibiotic treatment guidelines for urinary tract infections in 15 European countries - results of an online survey.
Malmros K, Huttner BD, McNulty C, Rodríguez-Baño J, Pulcini C, Tängdén T; ESGAP UTI working group. Int J Antimicrob Agents 2019 pii: S0924-857930168-2. doi: 10.1016/j.ijantimicag.2019.06.015. - Comparison of antimicrobial stewardship programs in acute care hospitals in four European countries: a cross-sectional survey.
Kallen MC, Binda F, Ten Oever J et al. Int J Antimicrob Agents 2019 pii: S0924-857930146-3. doi: 10.1016/j.ijantimicag.2019.06.005. - Essential and Forgotten antibiotics: an inventory in low- and middle-income countries.
Tebano G, Li G, Beovic B et al. Int J Antimicrob Agents 2019 pii: S0924-857930170-0. doi: 10.1016/j.ijantimicag.2019.06.017. - Nationwide survey of hospital antibiotic stewardship programs in France.
Binda F, Tebano G, Kallen MC, et al. Med Mal Infect 2019. pii: S0399-077X(18)30827-8. doi: 10.1016/j.medmal.2019.09.007. - Impact of the French Infectious Diseases Society's (SPILF) proposals for shorter antibiotic therapies.
Macheda G, Luc 2, Béraud G, et al. Med Mal Infect 2019;49(6):456-462. doi: 10.1016/j.medmal.2019.07.005. - Rapid Analysis of Diagnostic and Antimicrobial Patterns in R (RadaR): Interactive Open-Source Software App for Infection Management and Antimicrobial Stewardship.
Luz CF, Berends MS, Dik JH, et al. J Med Internet Res 2019;21(6):e12843. doi: 10.2196/12843.
ESGB
- Candida albicans enhances initial biofilm growth of Cutibacterium acnes under aerobic conditions.
Bernard C, Lemoine V, Hoogenkamp MA, et al. Biofouling 2019;35(3):350-360. doi: 10.1080/08927014.2019.1608966. - Minimum information guideline for spectrophotometric and fluorometric methods to assess biofilm formation in microplates
Allkjaa J, Bjarnsholt T, Coenye T, et al. Biofilm 2020. doi:10.1016/j.bioflm.2019.100010 - The future of biofilm research – Report on the ‘2019 Biofilm Bash’
Coenye T, Kjellerup B, Stoodley P, et al. Biofilm 2020. doi:10.1016/j.bioflm.2019.100012.
ESGBIES
- Extended infusion of β-lactams for bloodstream infection in patients with
liver cirrhosis: an observational multicenter study.
Bartoletti M, Giannella M, Lewis RE. Clin Infect Dis 2019. doi: 10.1093/cid/ciz032. - Microbiological diagnostics of bloodstream infections in Europe – An ESGBIES survey
EA. Idelevich et al. Clinical Microbiology and Infection. 2019 pii: S1198-743X30143-0. doi:10.1016/j.cmi.2019.03.024 - External validation of the INCREMENT-CPE mortality score in a carbapenem-resistant Klebsiella pneumoniae bacteraemia cohort: the prognostic significance of colistin resistance.
Machuca I, Gutiérrez-Gutiérrez B, Rivera-Espinar F, et al. Int J Antimicrob Agents 2019;54(4):442-448. doi: 10.1016/j.ijantimicag.2019.07.017. - Bloodstream infections - Standard and progress in pathogen diagnostics.
Lamy B, Sundqvist M, Idelevich EA et al. Clin Microbiol Infect 2019. pii: S1198-743X(19)30616-0. doi: 10.1016/j.cmi.2019.11.017. - Bacterial bloodstream infection
Allerberger F, Kern WV. Clin Microbiol Infect 2019. pii: S1198-743X30531-2. doi: 10.1016/j.cmi.2019.10.004. - Burden of bacterial bloodstream infection - A brief update on epidemiology and significance of multidrug-resistant pathogens.
Kern WV, Rieg S. Clin Microbiol Infect 2019. pii: S1198-743X(19)30586-5. doi: 10.1016/j.cmi.2019.10.031.
ESGBOR
- Review of European and American guidelines for the diagnosis of Lyme
borreliosis.
Eldin C, Raffetin A, Bouiller K, et al. Med Mal Infect 2019;49:121-132.
doi: 10.1016/j.medmal.2018.11.011. - Inflammatory Immune Responses in the Pathogenesis of Tick-Borne Encephalitis.
Bogovič P et al. J Clin Med 2019;8. pii: E731. doi: 10.3390/jcm8050731. - Unconventional diagnostic tests for Lyme borreliosis: a systematic review.
Raffetin A, Saunier A, Bouiller K, et al. Clin Microbiol Infect 2020;26(1):51-59. doi: 10.1016/j.cmi.2019.06.033. - Ticks and tick-borne diseases.
Boulanger N, Boyer P, Talagrand-Reboul E, Hansmann Y. Med Mal Infect 2019;49(2):87-97. doi: 10.1016/j.medmal.2019.01.007.
ESGCD
- A two-step approach for the investigation of a Clostridium difficile outbreak by molecular methods.
Krutova M, Wilcox MH, Kuijper EJ. Clin Microbiol Infect 2019; 25(11):1300-1301. doi: 10.1016/j.cmi.2019.07.022. - The emergence of Clostridium difficile ribotypes 027 and 176 with a predominance of the Clostridium difficile ribotype 001 recognized in Slovakia following the European standardized Clostridium difficile infection surveillance of 2016.
Novakova E, Stefkovicova M, Kopilec MG, et al. Int J Infect Dis 2020;90:111-115. doi: 10.1016/j.ijid.2019.10.038. - Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study.
Freeman J, Vernon J, Pilling S, et al. Eur J Clin Microbiol Infect Dis 2020;39(1):169-177. doi: 10.1007/s10096-019-03708-7. - The emergence of metronidazole and vancomycin reduced susceptibility in Clostridium difficile isolates in Iran.
Kouhsari E, Douraghi M, Krutova M, et al. J Glob Antimicrob Resist 2019;18:28-33. doi: 10.1016/j.jgar.2019.01.027.
ESGCIP
- Influenza and associated co-infections in critically ill immunosuppressed patients.
Martin-Loeches I, Lemiale V, Geoghegan P, et al.Crit Care 2019;23:152. doi: 10.1186/s13054-019-2425-6. - Factors associated with ventilator-associated events: an international multicenter prospective cohort study
Rello J, Ramírez-Estrada S, Romero A et al. European Journal of Clinical Microbiology & Infectious Diseases 2019, in press doi:10.1007/s10096-019-03596-x - Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project.
Bassetti M, Giacobbe DR, Vena A et al. Crit Care 2019; 23:219. doi: 10.1186/s13054-019-2497-3. - Rapid microbiological tests for bloodstream infections due to multidrug resistant Gram-negative bacteria: therapeutic implications.
Giacobbe DR, Giani T, Bassetti M, Marchese A, Viscoli C, Rossolini GM. Clin Microbiol Infect 2019. pii: S1198-743X30524-5. doi: 10.1016/j.cmi.2019.09.023.
ESGCP
- Child health, parasites and lower socioeconomic status: Outcomes of a long-term screening, intervention and training study by health volunteers in rural Nepal.
Sürmeli A, Tolunay T, Yasin Y, et al. Acta Trop 2020;202:105263. doi: 10.1016/j.actatropica.2019.105263. - Imported malaria in semi-immune and non-immune travelers in non-malaria-endemic countries. Mischlinger J, Rönnberg C, Álvarez-Martínez M, et al. Clinical Microbiology Reviews 2020. Accepted
ESGEM
- Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread.
David S, Reuter S, Harris SR, et al. Nat Microbiol 2019. doi: 10.1038/s41564-019-0492-8.https://www.ncbi.nlm.nih.gov/pubmed/30641227
ESGFOR
- Post-mortem microbiology sampling following death in hospital: an ESGFOR
task force consensus statement.
Burton JL, Saegeman V, Arribi A. J Clin Pathol 2019 in press. doi: 10.1136/jclinpath-2018-205365. - Post-mortem microbiology in sudden death: sampling protocols proposed in different clinical settings.
Fernández-Rodríguez A, Burton JL, Andreoletti L, et al. Clin Microbiol Infect 2019;25:570-579. doi: 10.1016/j.cmi.2018.08.009. - Mortality due to Cryptococcus neoformans and Cryptococcus gattii in low-income settings: an autopsy study.
Hurtado JC, Castillo P, Fernandes F, et al. Sci Rep 2019;9(1):7493. doi: 10.1038/s41598-019-43941-w.
ESGIAI
- Suppressive antibiotic therapy in prosthetic joint infections: a multicentre cohort study.
Escudero-Sanchez R, Senneville E, Digumber M, et al. Clin Microbiol Infect 2019. pii: S1198-743X(19)30492-6. doi: 10.1016/jcmi2019.09.007. - Multidrug-resistant and extensively drug-resistant Gram-negative prosthetic
joint infections: Role of surgery and impact of colistin administration.
Papadopoulos A, Ribera A, Mavrogenis AF, et al. Int J Antimicrob Agents 2019;53:294-301. doi: 10.1016/j.ijantimicag.2018.10.018 - Corrigendum to "Multidrug-resistant and extensively drug-resistant Gram-negative
prosthetic joint infections: Role of surgery and impact of colistin administration"
Papadopoulos A, Ribera A, Mavrogenis AF, et al. Int J Antimicrob Agents 2019;S0924-8579(19)30058-5. doi: 10.1016/j.ijantimicag.2019.03.005. - Clinical outcome and risk factors for failure in late acute prosthetic joint
infections treated with debridement and implant retention.
Wouthuyzen-Bakker M, Sebillotte M, Lomas J, et al. J Infect 2019;78:40-47. doi: 10.1016/j.jinf.2018.07.014. - Timing of implant-removal in late acute periprosthetic joint infection: A multicenter observational study.
Wouthuyzen-Bakker M, Sebillotte M, Lomas J, et al, J Infect 2019;79:199-205. doi: 10.1016/j.jinf.2019.07.003. - Antibiotic Use in Total Knee Arthroplasty Periprosthetic Joint Infection.
Wouthuyzen-Bakker M, Lora-Tamayo J, Soriano A; ESCMID Study Group for Implant-associated Infections. Clin Infect Dis 2019 pii: ciz631. doi: 10.1093/cid/ciz631 - Debridement, antibiotics and implant retention is a viable treatment option for early periprosthetic joint infection presenting more than four weeks after index arthroplasty.
Löwik CAM, Parvizi J, Jutte PC et al. Clin Infect Dis 2019. pii: ciz867. doi: 10.1093/cid/ciz867.
ESGIB
- Herpes simplex virus encephalitis update.
Stahl JP, Mailles A. Curr Opin Infect Dis 2019;32:239-243. doi: 10.1097/QCO.0000000000000554. - Understanding central nervous system efficacy of antimicrobials.
Tattevin P, Solomon T, Brouwer MC. Intensive Care Med 2019;45:93-96. doi: 10.1007/s00134-018-5270-1. - Update in Neurocritical Care: a summary of the 2018 Paris international conference of the French Society of Intensive Care.
Oddo M, Bracard S, Cariou A, et al. Ann Intensive Care 2019 doi: 10.1186/s13613-019-0523-x. - Metformin mediates neuroprotection and attenuates hearing loss in experimental pneumococcal meningitis.
Muri L, Le ND, Zemp J et al.J Neuroinflammation 2019 doi: 10.1186/s12974-019-1549-6. - Sex-based differences in the response to dexamethasone in bacterial meningitis: Analysis of the European dexamethasone in adulthood bacterial meningitis study.
Dias SP, Brouwer MC, van de Beek D. Br J Clin Pharmacol 2019. doi: 10.1111/bcp.14163. - Novel and preclinical treatment strategies in pneumococcal meningitis.
Bewersdorf JP, Grandgirard D, Koedel U, Leib SL. Curr Opin Infect Dis 2018;31(1):85-92. doi: 10.1097/QCO.0000000000000416. - Impact of pre-hospital antibiotic therapy on mortality in invasive meningococcal disease: a propensity score study.
Cabellos C, Pelegrín I, Benavent E, et al. Eur J Clin Microbiol Infect Dis 2019;38(9):1671-1676. doi: 10.1007/s10096-019-03599-8. - Combining Ceftriaxone with Doxycycline and Daptomycin Reduces Mortality, Neuroinflammation, Brain Damage, and Hearing Loss in Infant Rat Pneumococcal Meningitis.
Muri L, Perny M, Zemp J, et al. Antimicrob Agents Chemother 2019;63(7). pii: e00220-19. doi: 10.1128/AAC.00220-19. - Prediction of unfavorable outcomes in West Nile virus neuroinvasive infection - Result of a multinational ID-IRI study.
Popescu CP, Florescu SA, Hasbun R, et al. J Clin Virol. 2019 doi: 10.1016/j.jcv.2019.104213. - Long-term mortality and epilepsy in patients after brain abscess: A nationwide population-based matched cohort study.
Bodilsen J, Dalager-Pedersen M, van de Beek D, et al. Clin Infect Dis 2019. pii: ciz1153. doi: 10.1093/cid/ciz1153.
ESGICH
- Re: 'ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies' by Mikulska et al.
Wijetilleka S, Jayne D, Mukhtyar C, Karim MY. Clin Microbiol Infect 2019;25:531-532. doi: 10.1016/j.cmi.2018.12.025.
ESGIE
- Accuracy of comprehensive PCR analysis of nasopharyngeal and oropharyngeal swabs for CT-scan-confirmed pneumonia in elderly patients: a prospective cohort study.
Prendki V, Huttner B, Marti C, et al. Clin Microbiol Infect 2019; In press. doi: 10.1016/j.cmi.2018.12.037. - Antimicrobial consumption and impact of antimicrobial stewardship programmes in long-term care facilities.
Falcone M, Paul M, Yahav D, et al. Clin Microbiol Infect 2019;25:562-569. doi:10.1016/j.cmi.2018.07.028. - Rational Use of CT-Scan for the Diagnosis of Pneumonia: Comparative Accuracy of Different Strategies.
Garin N, Marti C, Carballo S et al. J Clin Med 2019 pii: E514. doi: 10.3390/jcm8040514. - Management of elderly patients with infective endocarditis.
Prendki V. Clin Microbiol Infect. 2019 doi: 10.1016/j.cmi.2019.06.023. - Attention to age: similar dosing regimens lead to different vancomycin levels among older and younger patients.
Yahav D, Abbas M, Nassar L, et al. Age Ageing 2019;49(1):26-31. doi: 10.1093/ageing/afz135. - Pneumonia prevention in the elderly patients: the other sides.
Chebib N, Cuvelier C, Malézieux-Picard A, et al. Aging Clin Exp Res 2019. doi: 10.1007/s40520-019-01437-7.
ESGITM
- National approaches to the vaccination of recently arrived migrants in Europe: A comparative policy analysis across 32 European countries.
Ravensbergen SJ, Nellums LB, Hargreaves S, Stienstra Y, Friedland JS. Travel Med Infect Dis 2019;27:33-38. doi: 10.1016/j.tmaid.2018.10.011. - Two cases of imported hemorrhagic fever with renal syndrome and systematic review of literature.
Puca E, Qato M, Pipero P, Akshija I, Kote M, Kraja D. Travel Med Infect Dis 2019;28:86-90. doi: 10.1016/j.tmaid.2018.07.010. - Proportion of asylum seekers carrying multi-drug resistant microorganisms is persistently increased after arrival in the Netherlands.
Ravensbergen SJ, Louka C, Ott A et al. Antimicrob Resist Infect Control 2019;8:6. doi: 10.1186/s13756-018-0455-5. - Asylum seekers' perspectives on vaccination and screening policies after their arrival in Greece and The Netherlands.
Louka C, Chandler E, Ranchor AV et al. PLoS One 2019;14(12):e0226948. doi: 10.1371/journal.pone.0226948. - Occupational health outcomes among international migrant workers: a systematic review and meta-analysis.
Hargreaves S, Rustage K, Nellums LB, et al. Lancet Glob Health. 2019;7(7):e872-e882. doi: 10.1016/S2214-109X(19)30204-9. - Parasitic skin infections: neglected diseases or just challenging for diagnosis?
Gardini G, Tomasoni LR, Castelli F. Curr Opin Infect Dis 2020. doi: 10.1097/QCO.0000000000000634.
ESGLI
- A real-time PCR for specific detection of the Legionella pneumophila serogroup 1 ST1 complex.
Ginevra C, Chastang J, David S et al. Clin Microbiol Infect 2019. pii: S1198-743X30487-2. doi: 10.1016/j.cmi.2019.09.002.
ESGMAC
- Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016.
Beeton ML, Zhang XS, Uldum SA, et al. Euro Surveill 2020;25(2). doi: 10.2807/1560-7917.ES.2020.25.2.1900112.
ESGMD
- How do advanced diagnostics support public health policy development?
Moran-Gilad J. Euro Surveill 2019;24. doi: 10.2807/1560-7917.ES.2019.24.4.1900068. - Operational models and criteria for incorporating microbial whole genome sequencing in hospital microbiology - A systematic literature review.
Mintzer V, Moran-Gilad J, Simon-Tuval T et al.Clin Microbiol Infect 2019; pii: S1198-743X30196-X. doi: 10.1016/j.cmi.2019.04.019. - ESCMID/ESGMD postgraduate technical workshop on diagnostic microbiology.
Scherler A, Ardissone S, Moran-Gilad J, Greub G. Microbes Infect 2019 pii: S1286-457930053-X. doi: 10.1016/j.micinf.2019.04.006. - Developmental roadmap for antimicrobial susceptibility testing systems.
van Belkum A, Bachmann TT, Lüdke G, et al. Nat Rev Microbiol 2019;17:51-62.
doi: 10.1038/s41579-018-0098-9 - The successful uptake and sustainability of rapid infectious disease and antimicrobial resistance point-of-care testing requires a complex 'mix-and-match' implementation package.
Hays JP, Mitsakakis K, Luz S, et al. Eur J Clin Microbiol Infect Dis 2019 doi: 10.1007/s10096-019-03492-4.
ESGNI
- Infection control bundles in intensive care: an international cross-sectional
survey in low- and middle-income countries.
Alp E, Cookson B, Erdem H, Rello J. J Hosp Infect 2019;101:248-256. doi: 10.1016/j.jhin.2018.07.022. - Prion disease and recommended procedures for flexible endoscope reprocessing - review of policies worldwide and proposal for a simplified approach.
Kampf G, Jung M, Suchomel M, Saliou P, Griffiths H, Vos MC. J Hosp Infect 2019 pii: S0195-670130317-2. doi: 10.1016/j.jhin.2019.08.005. - Analysis of the challenges in implementing guidelines to prevent the spread of multidrug-resistant gram-negatives in Europe.
Tacconelli E et al. BMJ Open 2019;9:e027683. doi: 10.1136/bmjopen-2018-027683.
ESGPHM
- NGS-based phylogeny of diphtheria-related pathogenicity factors in different Corynebacterium spp.
implies species-specific virulence transmission.
Dangel A, Berger A, Konrad R, Sing A. BMC Microbiol 2019;19:28. doi: 10.1186/s12866-019-1402-1. - Tox-positive Corynebacterium ulcerans in hedgehogs, Germany.
Berger A, Dangel A, Peters M, et al. Emerg Microbes Infect 2019;8:211-217. doi: 10.1080/22221751.2018.1562312. - Acute flaccid myelitis caused by enterovirus D68: Case definitions for use in clinical practice.
Kramer R, Lina B, Shetty J. Eur J Paediatr Neurol 2019;23:235-239. doi: 10.1016/j.ejpn.2019.01.001.
ESGS
- Implications of identifying the recently defined members of the S. aureus
complex, S. argenteus and S. schweitzeri: A position paper of members of
the ESCMID Study Group for staphylococci and Staphylococcal Diseases
(ESGS).
Becker K, Schaumburg F, Kearns A et al. Clin Microbiol Infect 2019 in press.
doi: 10.1016/j.cmi.2019.02.028.
ESGVH
- Hepatitis C: Is eradication possible?
Lombardi A, Mondelli MU, Liver Int 2019;39:416-426. doi: 10.1111/liv.14011. - Liver decompensation in HIV/Hepatitis B coinfection in the combination
antiretroviral therapy era does not seem increased compared to hepatitis B
mono-infection.
Lieveld FI, Smit C, Richter C, et al. Liver Int 2019;39:470-483. doi: 10.1111/liv.14000. - Elimination of hepatitis C in Europe: can WHO targets be achieved?
Maticic M, Lombardi A, Mondelli MU, et al. Clin Microbiol Infect 2020 21. pii: S1198-743X(20)30039-2. doi: 10.1016/j.cmi.2020.01.014.
ESGVM
- Specific staphylococcal cassette chromosome mec (SCCmec) types and clonal complexes are associated with low-level amoxicillin/clavulanic acid and cefalotin resistance in methicillin-resistant Staphylococcus pseudintermedius.
Wegener A, Damborg P, Guardabassi L, et al. J Antimicrob Chemother 2019. pii: dkz509. doi: 10.1093/jac/dkz509.
EVASG
- Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines.
Esposito S, Stefanelli P, Fry NK, et al. Front Immunol 2019;10:1344. doi: 10.3389/fimmu.2019.01344. - 5TH ESCMID Conference on vaccines in Bilbao, Spain. Vaccines against respiratory infections: New insights and new vaccines.
Esposito S. Hum Vaccin Immunother 2019. doi: 10.1080/21645515.2019.1678999.
EFISG & ESGICH
- Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: results of an international practice survey from ESCMID Fungal Infection Study Group and Study Group for Infections in Compromised Hosts, and European Confederation of Medical Mycology.
Rammaert B, Puyade M, Cornely OA et al. Transpl Infect Dis 2019:e13141. doi: 10.1111/tid.13141.
ESGMD & ESGAP
- Diagnostic stewardship: are we using the right term?
Dyar OJ, Moran-Gilad J, Greub G, Pulcini C. Clin Microbiol Infect 2019;25:272-273. doi: 10.1016/j.cmi.2018.12.011.
ESGAP & TAE
- Young doctors' perspectives on antibiotic use and resistance: a multinational and inter-specialty cross-sectional European Society of Clinical Microbiology and Infectious Diseases (ESCMID) survey.
Beović B, Doušak M, Pulcini C et al. J Antimicrob Chemother 2019. pii: dkz375. doi: 10.1093/jac/dkz375.
ESGCIP & EFISG & ESCMID
- Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project.
Bassetti M, Scudeller L, Giacobbe DR et al. Mycoses 2019;62:310-319. doi: 10.1111/myc.12869.
ESGAP & EUCIC & TAE
- Organization and training at national level of antimicrobial stewardship and infection control activities in Europe: an ESCMID cross-sectional survey.
Maraolo AE, Ong DSY, Cimen C et al. Eur J Clin Microbiol Infect Dis 2019 doi: 10.1007/s10096-019-03648-2.
Publications from recipients (*) of ESCMID Research Grants
- Usefulness of guideline recommendations for prognosis in patients with candidemia.
Cuervo G, Garcia-Vidal C*, Puig-Asensio M, et al. Med Mycol 2019;57(6):659-667. doi: 10.1093/mmy/myy118. - Global burden of melioidosis in 2015: a systematic review and data synthesis.
Birnie E*, Virk HS, Savelkoel Jet al. Lancet Infect Dis 2019 pii: S1473-309930157-4. doi: 10.1016/S1473-309930157-4. - Revisiting anti-tuberculosis therapeutic strategies that target the
peptidoglycan structure and synthesis.
Catalão MJ*, Filipe SR, Pimentel M. Front Microbiol 2019;11;10:190.
doi: 10.3389/fmicb.2019.00190. - Disease Tolerance as an Inherent Component of Immunity.
Martins R, Carlos AR, Braza F, Thompson JA*, Bastos-Amador P, Ramos S, Soares MP.
Annu Rev Immunol 2019 in press. doi: 10.1146/annurev-immunol-042718-041739. - Fourier transform infrared spectroscopy: unlocking fundamentals and
prospects for bacterial strain typing.
Novais Â, Freitas AR*, Rodrigues C, Peixe L. Eur J Clin Microbiol Infect Dis 2019;38:427-448.
doi: 10.1007/s10096-018-3431-3. - EUCAST susceptibility testing of isavuconazole: MIC data for contemporary
clinical mould and yeast isolates.
Jørgensen KM, Astvad KMT, Hare RK, Arendrup* MC. Antimicrob Agents Chemother 2019. pii: AAC.00073-19. doi: 10.1128/AAC.00073-19. - Role of AcrAB-TolC multidrug efflux pump in drug-resistance acquisition by plasmid transfer.
Nolivos S, Cayron J, Dedieu A, Page A, Delolme F, Lesterlin C*. Science 2019;364:778-782. doi: 10.1126/science.aav6390 - Candida albicans enhances initial biofilm growth of Cutibacterium acnes under aerobic conditions.
Bernard C, Lemoine V, Hoogenkamp MA, Girardot M*, Krom BP, Imbert C. Biofouling 2019:1-11. doi: 10.1080/08927014.2019.1608966 - Host metabolites stimulate the bacterial proton motive force to enhance the activity of aminoglycoside antibiotics.
Crabbé A*, Ostyn L, Staelens S et al. PLoS Pathog 2019 29;15:e1007697. doi: 10.1371/journal.ppat.1007697. - Elevated risk of invasive group A streptococcal disease and host genetic variation in the human leucocyte antigen locus.
Parks T*, Elliott K, Lamagni T et al. Genes Immun 2019. doi: 10.1038/s41435-019-0082-z. - Association of Leukotriene A4 Hydrolase with Tuberculosis Susceptibility Using Genomic Data in Portugal.
Rito T*, Ferreira J, Cavadas B et al. Microorganisms 2019 doi: 10.3390/microorganisms7120650. - Voriconazole efficacy against Candida glabrata and Candida krusei: preclinical data using a validated in vitro pharmacokinetic/pharmacodynamic model.
Beredaki MI, Georgiou PC, Siopi M, Kanioura L, Arendrup MC, Mouton JW, Meletiadis J*. J Antimicrob Chemother 2020;75(1):140-148. doi: 10.1093/jac/dkz425. - Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: The impact of cytomegalovirus disease and lymphopenia.
Pérez-Nadales E, Gutiérrez-Gutiérrez B, Natera AM, ..., María Aguado J*, et al. Am J Transplant 2019. doi: 10.1111/ajt.15769.
Publications from participants (*) of ESCMID Mentorship programme
- High prevalence of division II (cfiA positive) isolates among blood stream Bacteroides fragilis in Slovenia as determined by MALDI-TOF MS.
Jeverica S*, Sóki J, Premru MM, Nagy E*, Papst L. Anaerobe 2019;58:30-34. doi: 10.1016/j.anaerobe.2019.01.011.
